Health Secretary Robert F. Kennedy Jr. Endorses Broader RSV Vaccine Use, Following Guidance from Former ACIP Panel Despite ousting the Centers for Disease Control and Prevention’s (CDC) vaccine advisory panel…
Stallergenes Greer Appoints CEOLIA as New Promotional Partner for Actair® in Japan, Concluding 13-Year Collaboration with Shionogi Stallergenes Greer, a global leader in allergen immunotherapy, has announced a strategic transition…
WHO Concludes Participation in Major Global Nuclear Emergency Simulation The World Health Organization (WHO) has successfully concluded its role in a high-stakes, 36-hour nuclear emergency simulation exercise organized by the…
CroíValve Awarded €12.5M in Horizon Europe EIC Accelerator Funding to Advance Novel Treatment for Tricuspid Regurgitation CroíValve, a Dublin-based medical device company committed to transforming the treatment of tricuspid regurgitation…
Comprehensive Report Reveals Key Trends in Gynecology Collaboration and Licensing Deals from 2016 to 2025 Gynecology Collaboration and Licensing Deals report offers a deep dive into the evolving landscape of…
Synedgen Appoints Dr. Laura Saward as CEO and Dr. Kenton Gregory as CMO Amid Strategic Growth Synedgen, Inc., a biotechnology company pioneering treatments based on human glycobiology, has announced significant…
Dyadic International Rebrands as Dyadic Applied BioSolutions, Marking Strategic Shift Toward Commercial Bioprocessing Solutions Dyadic International, Inc. (Nasdaq: DYAI), a global biotechnology company known for its proprietary gene expression platforms,…
Biosynth Unveils Expanded GMP Bioconjugation Facility in Berlin to Advance Next-Generation Therapeutics Biosynth, a global leader in providing essential raw materials and services for the life sciences and diagnostics industries,…
Medimaps Group Launches Next-Generation TBS Osteo Software Across Europe to Revolutionize Osteoporosis Detection Medimaps Group S.A., a Swiss-based global leader in AI-powered bone health solutions, has announced the European launch…
Novocure to Present Final PANOVA-3 Data Highlighting Pain and Quality of Life Benefits of TTFields Therapy in Pancreatic Cancer at ESMO GI 2025 Novocure (NASDAQ: NVCR) announced that it will…
Experimental Drug AC102 Significantly Reverses Tinnitus and Repairs Auditory Damage in Preclinical Study A groundbreaking preclinical study has shown that a single dose of the novel compound AC102 can nearly…
Sunshine Biopharma Launches NIOPEG® Biosimilar in Canada, Targeting $10B Biologics Market Sunshine Biopharma Inc. (NASDAQ: SBFM), a pharmaceutical company focused on developing and commercializing life-saving medicines across oncology, antiviral therapies,…